| Dr Sultana Begum, MD | |
|
1910 Cherokee Ave Sw, Cullman, AL 35055-5502 | |
| (256) 739-3500 | |
| (256) 736-1093 |
| Full Name | Dr Sultana Begum |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 43 Years |
| Location | 1910 Cherokee Ave Sw, Cullman, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457304909 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 00024528 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Pennsylvania Physician Alliance, Llc | 8325478662 | 92 |
News Archive
Researchers across 13 European and African research institutes will work together to integrate data from climate modelling and disease forecasting systems to predict the likelihood of an epidemic up to six months in advance. The research, funded by the European Commission Seventh Framework programme, will focus on climate and disease in Senegal, Ghana and Malawi and aims to give decision makers the necessary time to deploy intervention methods to help prevent large scale spread of diseases such as Rift Valley Fever and malaria.
Older adults who have had a heart attack don't tend to adhere to their prescribed drugs according to a new study of Medicare beneficiaries by the University of Maryland School of Pharmacy.
Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.
Efforts by the U.S. Department of Education to encourage school preparedness for learning continuity during prolonged absences or emergency dismissals due to H1N1 flu outbreaks included a recent tour of a closure simulation at VOISE Academy, a Chicago public school.
› Verified 5 days ago
| Entity Name | Uhs Of Pennsylvania, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124091715 PECOS PAC ID: 3971407438 Enrollment ID: O20050913000388 |
News Archive
Researchers across 13 European and African research institutes will work together to integrate data from climate modelling and disease forecasting systems to predict the likelihood of an epidemic up to six months in advance. The research, funded by the European Commission Seventh Framework programme, will focus on climate and disease in Senegal, Ghana and Malawi and aims to give decision makers the necessary time to deploy intervention methods to help prevent large scale spread of diseases such as Rift Valley Fever and malaria.
Older adults who have had a heart attack don't tend to adhere to their prescribed drugs according to a new study of Medicare beneficiaries by the University of Maryland School of Pharmacy.
Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.
Efforts by the U.S. Department of Education to encourage school preparedness for learning continuity during prolonged absences or emergency dismissals due to H1N1 flu outbreaks included a recent tour of a closure simulation at VOISE Academy, a Chicago public school.
› Verified 5 days ago
| Entity Name | Eastern Pennsylvania Physician Alliance, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902440621 PECOS PAC ID: 8325478662 Enrollment ID: O20200428001935 |
News Archive
Researchers across 13 European and African research institutes will work together to integrate data from climate modelling and disease forecasting systems to predict the likelihood of an epidemic up to six months in advance. The research, funded by the European Commission Seventh Framework programme, will focus on climate and disease in Senegal, Ghana and Malawi and aims to give decision makers the necessary time to deploy intervention methods to help prevent large scale spread of diseases such as Rift Valley Fever and malaria.
Older adults who have had a heart attack don't tend to adhere to their prescribed drugs according to a new study of Medicare beneficiaries by the University of Maryland School of Pharmacy.
Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.
Efforts by the U.S. Department of Education to encourage school preparedness for learning continuity during prolonged absences or emergency dismissals due to H1N1 flu outbreaks included a recent tour of a closure simulation at VOISE Academy, a Chicago public school.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sultana Begum, MD 1910 Cherokee Ave Sw, Cullman, AL 35055 Ph: (256) 739-3500 | Dr Sultana Begum, MD 1910 Cherokee Ave Sw, Cullman, AL 35055-5502 Ph: (256) 739-3500 |
News Archive
Researchers across 13 European and African research institutes will work together to integrate data from climate modelling and disease forecasting systems to predict the likelihood of an epidemic up to six months in advance. The research, funded by the European Commission Seventh Framework programme, will focus on climate and disease in Senegal, Ghana and Malawi and aims to give decision makers the necessary time to deploy intervention methods to help prevent large scale spread of diseases such as Rift Valley Fever and malaria.
Older adults who have had a heart attack don't tend to adhere to their prescribed drugs according to a new study of Medicare beneficiaries by the University of Maryland School of Pharmacy.
Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.
Efforts by the U.S. Department of Education to encourage school preparedness for learning continuity during prolonged absences or emergency dismissals due to H1N1 flu outbreaks included a recent tour of a closure simulation at VOISE Academy, a Chicago public school.
› Verified 5 days ago
Deborah Gordon, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 503 Clark St Ne, Cullman, AL 35055 Phone: 256-739-1759 Fax: 256-739-0027 | |
Sabrina Gilley Payne, RN Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1909 Commerce Ave, Cullman, AL 35055 Phone: 256-734-4688 | |
Kenneth Robert Murray, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1890 Al Highway 157 Ste 102, Cullman, AL 35058 Phone: 256-903-0300 Fax: 256-801-7893 | |
Ajmal Muhammad Khan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1909 Commerce Ave, Cullman, AL 35055 Phone: 256-734-4688 | |
Dr. Mary Katherine Leonard Thrower, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 101 2nd Ave Se, Cullman, AL 35055 Phone: 256-739-4910 Fax: 256-739-9455 | |
Daniel Thomas Meadows Jr., MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 101 2nd Ave Se, Cullman, AL 35055 Phone: 256-739-4910 Fax: 256-739-9455 |